These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 38282550)
1. Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity. Shah SM; Demidova EV; Ringenbach S; Faezov B; Andrake M; Gandhi A; Mur P; Viana-Errasti J; Xiu J; Swensen J; Valle L; Dunbrack RL; Hall MJ; Arora S Cancer Res Commun; 2024 Jan; 4(1):213-225. PubMed ID: 38282550 [TBL] [Abstract][Full Text] [Related]
3. A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report. Cui J; Chen X; Zhai Q; Chen N; Li X; Zhang Y; Wang H; Bian X; Gao N; Chen D; Chen Z; Zhang S; Chen Y Diagn Pathol; 2023 Feb; 18(1):19. PubMed ID: 36765365 [TBL] [Abstract][Full Text] [Related]
4. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063 [TBL] [Abstract][Full Text] [Related]
5. Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns. Hu H; Cai W; Wu D; Hu W; Dong Wang L; Mao J; Zheng S; Ge W Cancer Med; 2021 Jan; 10(1):135-142. PubMed ID: 33125191 [TBL] [Abstract][Full Text] [Related]
6. A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma. Devereaux KA; Steiner DF; Ho C; Gomez AJ; Gilks B; Longacre TA; Zehnder JL; Howitt BE; Suarez CJ Int J Gynecol Pathol; 2022 Nov; 41(6):541-551. PubMed ID: 34907997 [TBL] [Abstract][Full Text] [Related]
7. Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants. Selves J; de Castro E Gloria H; Brunac AC; Saffi J; Guimbaud R; Brousset P; Hoffmann JS Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37891003 [TBL] [Abstract][Full Text] [Related]
8. Distinct mutational profile and immune microenvironment in microsatellite-unstable and Hwang HS; Kim D; Choi J J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607897 [TBL] [Abstract][Full Text] [Related]
9. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation. Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678 [TBL] [Abstract][Full Text] [Related]
10. Non-Exonuclease Domain POLE Mutations Associated with Immunotherapy Benefit. Dong S; Zakaria H; Hsiehchen D Oncologist; 2022 Mar; 27(3):159-162. PubMed ID: 35274726 [TBL] [Abstract][Full Text] [Related]
11. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557 [TBL] [Abstract][Full Text] [Related]
12. Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring Wen L; Chen Z; Ji X; Fong WP; Shao Q; Ren C; Cai Y; Li B; Yuan Y; Wang D; Li Y J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793867 [TBL] [Abstract][Full Text] [Related]
13. POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. van Gool IC; Eggink FA; Freeman-Mills L; Stelloo E; Marchi E; de Bruyn M; Palles C; Nout RA; de Kroon CD; Osse EM; Klenerman P; Creutzberg CL; Tomlinson IP; Smit VT; Nijman HW; Bosse T; Church DN Clin Cancer Res; 2015 Jul; 21(14):3347-3355. PubMed ID: 25878334 [TBL] [Abstract][Full Text] [Related]
14. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors. Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724 [TBL] [Abstract][Full Text] [Related]
15. POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction. Li Y; Bian Y; Wang K; Wan XP BMC Med Genet; 2019 Dec; 20(1):202. PubMed ID: 31864301 [TBL] [Abstract][Full Text] [Related]
16. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. Domingo E; Freeman-Mills L; Rayner E; Glaire M; Briggs S; Vermeulen L; Fessler E; Medema JP; Boot A; Morreau H; van Wezel T; Liefers GJ; Lothe RA; Danielsen SA; Sveen A; Nesbakken A; Zlobec I; Lugli A; Koelzer VH; Berger MD; Castellví-Bel S; Muñoz J; ; de Bruyn M; Nijman HW; Novelli M; Lawson K; Oukrif D; Frangou E; Dutton P; Tejpar S; Delorenzi M; Kerr R; Kerr D; Tomlinson I; Church DN Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):207-216. PubMed ID: 28404093 [TBL] [Abstract][Full Text] [Related]
17. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer. Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149 [TBL] [Abstract][Full Text] [Related]
18. Characterization of POLE c.1373A > T p.(Tyr458Phe), causing high cancer risk. Rocque MJ; Leipart V; Kumar Singh A; Mur P; Olsen MF; Engebretsen LF; Martin-Ramos E; Aligué R; Sætrom P; Valle L; Drabløs F; Otterlei M; Sjursen W Mol Genet Genomics; 2023 May; 298(3):555-566. PubMed ID: 36856825 [TBL] [Abstract][Full Text] [Related]
19. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East. Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Masoodi T; Siraj N; Al-Rasheed M; Kong Y; Ahmed SO; Al-Obaisi KAS; Victoria IG; Arshad M; Al-Dayel F; Abduljabbar A; Ashari LH; Al-Kuraya KS Mol Genet Genomic Med; 2020 Aug; 8(8):e1368. PubMed ID: 32567205 [TBL] [Abstract][Full Text] [Related]
20. Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients. Bellone S; Centritto F; Black J; Schwab C; English D; Cocco E; Lopez S; Bonazzoli E; Predolini F; Ferrari F; Silasi DA; Ratner E; Azodi M; Schwartz PE; Santin AD Gynecol Oncol; 2015 Jul; 138(1):11-7. PubMed ID: 25931171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]